Exicure, Inc. Profile Avatar - Palmy Investing

Exicure, Inc.

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic…

Biotechnology
US, Chicago [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of XCUR's Analysis
CIK: 1698530 CUSIP: 30205M101 ISIN: US30205M2008 LEI: - UEI: -
Secondary Listings
XCUR has no secondary listings inside our databases.